Shi-Cheng Zhao

Statistics

Publications

Citations

174

H-Index

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kettering University

Shi-Cheng Zhao is an author at Memorial Sloan Kettering Cancer Center specializing in molecular oncology, progenitor cells, and retroviral gene transfer.

Publications per year

1994–2001

Publications

Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells

Naoko Takebe, Shi-Cheng Zhao, Ali Uğur Ural et al. · Cancer Gene Therapy · 2001 · 56 citations

Life Sciences, Hematology, Molecular Biology +12

Post-Transplant Methotrexate Administration Leads to Improved Curability of Mice Bearing a Mammary Tumor Transplanted with Marrow Transduced with a Mutant Human Dihydrofolate Reductase cDNA

Shi-Cheng Zhao, Debabrata Banerjee, Shin Mineishi et al. · Human Gene Therapy · 1997 · 45 citations

Medicine, Oncology, Pharmacology +17

Generation of Dual Resistance to 4-Hydroperoxycyclophosphamide and Methotrexate by Retroviral Transfer of the Human Aldehyde Dehydrogenase Class 1 Gene and a Mutated Dihydrofolate Reductase Gene

Naoko Takebe, Shi-Cheng Zhao, Debasis Das Adhikari et al. · Molecular Therapy · 2001 · 44 citations · Full text

Medicine, Oncology, Pharmacology +15

Transfection with a cDNA encoding a Ser31 or Ser35 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance

Debabrata Banerjee, Barry Schweitzer, Matthias Volkenandt et al. · Gene · 1994 · 29 citations

Life Sciences, Biochemistry, Molecular Biology +10

1–4 of 4